2696 — Shanghai Henlius Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$38.97bn
- HK$42.17bn
- CNY6.67bn
Annual cashflow statement for Shanghai Henlius Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -957 | -694 | 570 | 846 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 336 | 299 | 161 | 106 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 511 | 1,099 | -41.8 | -84.9 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 90.4 | 982 | 1,048 | 1,242 | — |
| Capital Expenditures | -1,131 | -1,365 | -1,011 | -837 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -550 | 6.56 | 7.01 | -72.8 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,681 | -1,359 | -1,004 | -910 | — |
| Financing Cash Flow Items | -83.4 | -115 | -130 | -133 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 648 | 858 | 144 | -643 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -959 | 518 | 194 | -296 | — |